6月10日，截至港股收盘，恒生指数下跌0.08%，报24162.87点。加和国际控股（08513.HK）收报0.143 港元/股，上涨15.32%，成交量12万股，成交额1.72万港元，振幅0.81%。 来源：金融界 最近一个月来，加和国际控股累计跌幅11.43%，今年来累计跌幅29.94%，跑输恒生指数20.55%的涨 幅。 财务数据显示，截至2024年12月31日，加和国际控股实现营业总收入5565.65万元，同比增长14.33%； 归母净利润-1400.06万元，同比增长61%；毛利率2.18%，资产负债率75.71%。 行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为-21.39倍，行业中值0.3倍。加和国际 控股市盈率-6.71倍，行业排名第83位；其他巨星医疗控股（02393.HK）为0.22倍、京玖康疗 （00648.HK）为0.38倍、永胜医疗（01612.HK）为3.83倍、环球医疗（02666.HK）为4.7倍、瑞慈医疗 （01526.HK）为5.4倍。 机构评级方面，目前暂无机构对该股做出投资评级建议。 资料显示，加和国际控股有限公司为总部位於新加坡的合约制造商,制造及销售一 ...

财务数据显示，截至2024年12月31日，加和国际控股实现营业总收入5565.65万元，同比增长14.33%； 归母净利润-1400.06万元，同比增长61%；毛利率2.18%，资产负债率75.71%。 机构评级方面，目前暂无机构对该股做出投资评级建议。 5月30日，截至港股收盘，恒生指数下跌1.2%，报23289.77点。加和国际控股（08513.HK）收报0.145港 元/股，上涨11.54%，成交量6万股，成交额8380港元，振幅11.54%。 行业估值方面，医疗保健设备和服务行业市盈率（TTM）平均值为-20.22倍，行业中值0.3倍。加和国际 控股市盈率-7.04倍，行业排名第82位；其他巨星医疗控股（02393.HK）为0.22倍、京玖康疗 （00648.HK）为0.38倍、永胜医疗（01612.HK）为3.78倍、环球医疗（02666.HK）为4.64倍、瑞慈医疗 （01526.HK）为5.45倍。 最近一个月来，加和国际控股累计跌幅16.13%，今年来累计跌幅26.55%，跑输恒生指数17.51%的涨 幅。 （以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。） 来 ...

Financial Performance - For the fiscal year ending December 31, 2024, the company reported revenue of approximately SGD 10.5 million, an increase from SGD 9.1 million in the previous fiscal year[11]. - The gross profit turned positive at SGD 0.2 million, compared to a gross loss of SGD 0.7 million in the fiscal year 2023, indicating improved cost management[11]. - The net loss for the fiscal year 2024 was approximately SGD 2.6 million, significantly reduced from a net loss of SGD 6.8 million in the fiscal year 2023[11]. - The group's revenue increased by approximately SGD 1.4 million or 15.4% from SGD 9.1 million in FY2023 to approximately SGD 10.5 million in FY2024, primarily due to sales and manufacturing of disposable medical device injection molded plastic components in Singapore[19]. - The overall gross profit improved from a gross loss of approximately SGD 0.7 million in FY2023 to a gross profit of approximately SGD 0.2 million in FY2024, representing an increase of approximately SGD 0.9 million or 128.6%[21]. - The net other income increased from a net loss of approximately SGD 15,000 in FY2023 to a net other income of approximately SGD 0.2 million in FY2024, attributed to gains from lease termination and foreign exchange gains[23]. - Total comprehensive loss for the year was SGD 2,631,000, down from SGD 6,835,000 in 2023, showing a 61% improvement[173]. - The company reported a net loss from continuing operations of SGD 2,631,000 for 2024, compared to SGD 4,685,000 in 2023[173]. - Other income increased significantly to SGD 759,000 in 2024 from SGD 90,000 in 2023, marking a growth of 743%[173]. Operational Changes - The company successfully sold its gaming machines and equipment division in December 2023, allowing it to focus on core business areas[13]. - The company has ceased its gaming machine and equipment operations, focusing on manufacturing and selling disposable medical devices[185]. - The company continues to explore new revenue sources and business opportunities to mitigate external economic challenges[17]. - The company is committed to operational optimization and enhancing efficiency across its business units[13]. - Strategic resource allocation and strict cost control measures have been implemented to align business strategies with changing market conditions[12]. Governance and Management - The company has appointed new executive directors, including Mr. Li and Mr. Yang, effective from October 1, 2024, and November 22, 2024, respectively[49][50]. - The company’s founder, Mr. Pan, has been with the group since 1981 and plays a crucial role in overall management and business development[45]. - The board of directors includes experienced professionals with extensive backgrounds in finance, management, and consulting[51][53]. - The company emphasizes the importance of sound corporate governance for long-term success and sustainable development, maintaining high standards and procedures to enhance accountability and transparency[63]. - The company has complied with the corporate governance code, except for the provision that the roles of chairman and CEO should be separated, which is currently held by Mr. Pan[64]. - The board consists of seven members, including four executive directors and three independent non-executive directors, ensuring independent judgment[68]. - The company has established three functional committees to assist the board in fulfilling its responsibilities, including the audit committee, remuneration committee, and nomination committee[77]. - The company has adopted trading standards for directors' securities transactions, confirming compliance during the fiscal year 2024[75]. Financial Position and Cash Flow - The current ratio improved to approximately 1.8 times as of December 31, 2024, compared to 1.4 times in 2023, due to increases in trade and other receivables[29]. - The total borrowings decreased to approximately SGD 2.4 million as of December 31, 2024, down from SGD 4.2 million in 2023[30]. - The company reported a decrease in cash used in investing activities, with cash outflow for the purchase of property, plant, and equipment increasing to SGD 255,000 from SGD 47,000[183]. - The total cash and cash equivalents at the end of 2024 rose to SGD 1,779,000, up from SGD 1,598,000 at the end of 2023, indicating a positive cash flow trend[183]. - The company received a loan from a shareholder amounting to SGD 2,000,000, which was not present in the previous year[183]. - The company’s cash flow from operating activities was not detailed in the provided documents, indicating a need for further analysis in future reports[183]. Compliance and Risk Management - The company is committed to complying with insider information disclosure regulations and has engaged a third-party firm to review internal controls[98]. - The company confirmed that the consolidated financial statements for the fiscal year 2024 were prepared in accordance with relevant accounting standards and principles, reflecting the group's true and fair condition, performance, and cash flows[99]. - The audit committee discussed internal controls and financial reporting matters for the fiscal year 2024, confirming compliance with applicable standards and regulations[82]. - The independent auditor has confirmed that the consolidated financial statements reflect the group's financial position as of December 31, 2024, in accordance with International Financial Reporting Standards[157]. - The company has complied with applicable laws and regulations, ensuring that its operations meet significant legal requirements[119]. Shareholder Engagement - The board of directors is committed to maintaining effective and ongoing communication with shareholders and potential investors[101]. - The company encourages all shareholders to attend the annual general meeting and future meetings to maintain good communication[106]. - The company has received annual independence confirmations from all independent non-executive directors as required by GEM listing rules[129]. Future Outlook - Future outlook remains cautious with ongoing assessments of cash flow forecasts and key assumptions impacting financial performance[173]. - The company is actively exploring future development opportunities and market expansion strategies[41].

Dividend Information - The company does not recommend the payment of a final dividend for the fiscal year ending December 31, 2024[4] Performance Announcement - The annual performance announcement is scheduled for March 27, 2025, covering the fiscal year ending December 31, 2024[3] Information Accuracy and Transparency - The board of directors confirms the accuracy and completeness of the information provided in the announcement[4] - The company has a commitment to transparency and accountability regarding the information disclosed[4] - The company emphasizes that there are no misleading or fraudulent elements in the announcement[4] Regulatory Compliance - The announcement aims to provide information about the company in accordance with the GEM listing rules[4] Publication Details - The announcement will be published on the Hong Kong Stock Exchange website for at least seven days from the publication date[4] - The announcement will also be available on the company's official website[4] Company Information - The company is registered in the Cayman Islands and operates under the stock code 8513[2] - The board consists of both executive and independent non-executive directors[4]

截至二零二四年十二月三十一日止年度 全年業績公告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，該等公司較其他在聯交所上市的公 司具有更高投資風險。有意投資者應了解投資於該等公司的潛在風險，並應經過審慎周 詳考慮後方作出投資決定。 MaxWin International Holdings Limited 加和國際控股有限公司 （ 於 開 曼 群 島 註 冊 成 立 的 有 限 公 司 ） （股份代號：8513） 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣的證券承 受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本公告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 本公告乃遵照聯交所GEM證券上市規則（「GEM上市規則」）的規定而刊載，旨在提供有關 加和國際控股有限公司（「本公司」，連同其附屬公司，統稱「本集團」）的資料；本公司的 董事（「董事」）願就本公告共同及個 ...

MaxWin International Holdings Limited 加和國際控股有限公司 （前稱IAG Holdings Limited 官醞控股有限公司） （於開曼群島註冊成立的有限公司） （股份代號：8513） 2024 中期報告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，該等公司較其他在聯交所上市的 公司具有更高投資風險。有意投資者應了解投資於該等公司的潛在風險，並應經過審 慎周詳考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣的證 券承受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性 亦不發表任何聲明，並明確表示，概不對因本報告全部或任何部分內容而產生或因倚 賴該等內容而引致的任何損失承擔任何責任。 本報告乃遵照聯交所GEM證券上市規則（「GEM上市規則」）的規定而刊載，旨在提供 有關加和國際控股有限公司（「本公司」，連同其附屬公司，「本集團」）的資料；本公司 的董事（「董事」）願就本報告共同 ...

MaxWin International Holdings Limited 加和國際控股有限公司 （前稱 IAG Holdings Limited官醞控股有限公司） （於開曼群島註冊成立的有限公司） （股份代號：8513） 截至二零二四年六月三十日止六個月 中期業績公告 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，該等公司較其他在聯交所上市的公 司具有更高投資風險。有意投資者應了解投資於該等公司的潛在風險，並應經過審慎周 詳考慮後方作出投資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣的證券承 受較大的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本公告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示，概不對因本公告全部或任何部分內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 本公告乃遵照聯交所GEM證券上市規則（「GEM上市規則」）的規定而刊載，旨在提供有關 加和國際控股有限公司（「本公司」，連同其附屬公司，「本集團」）的資料；本公司的董事 ...

2023 MaxWin International Holdings Limited 加和國際控股有限公司 （股份代號：8513） （前稱IAG Holdings Limited 官醞控股有限公司） （於開曼群島註冊成立的有限公司） 年報 香港聯合交易所有限公司（「聯交所」）GEM的特色 GEM的定位，乃為中小型公司提供一個上市的市場，該等公司較其他在聯交所上市的公司具有更 高投資風險。有意投資者應了解投資於該等公司的潛在風險，並應經過審慎周詳考慮後方作出投 資決定。 由於GEM上市公司普遍為中小型公司，在GEM買賣的證券可能會較於主板買賣的證券承受較大 的市場波動風險，同時無法保證在GEM買賣的證券會有高流通量的市場。 香港交易及結算所有限公司及聯交所對本報告的內容概不負責，對其準確性或完整性亦不發表任 何聲明，並明確表示，概不對因本報告全部或任何部分內容而產生或因倚賴該等內容而引致的任 何損失承擔任何責任。 本報告乃遵照聯交所GEM證券上市規則（「GEM上市規則」）的規定而刊載，旨在提供有關加和國 際控股有限公司（前稱官醞控股有限公司）（「本公司」，連同其附屬公司，「本集團」）的資料；本公 司的董事（「董 ...

Dividend Policy - MaxWin International Holdings Limited does not recommend the payment of a final dividend for the year ended December 31, 2023[2] Compliance and Governance - The announcement is in compliance with the GEM Listing Rules of the Hong Kong Stock Exchange[4] - The board of directors confirms that the information provided is accurate and complete in all material aspects[4]

Financial Performance - The company's revenue for the year ended December 31, 2023, was SGD 9,148,000, a decrease of 34.5% compared to SGD 13,898,000 in 2022[4] - The total comprehensive loss for the year was SGD 6,835,000, compared to SGD 3,246,000 in the previous year, reflecting a worsening financial position[4] - The group reported a net loss of approximately SGD 6,847,000 for the year ended December 31, 2023, compared to a loss of SGD 3,063,000 for the previous year[14] - The company reported a total loss for the year of SGD 6,847,000, compared to a loss of SGD 3,063,000 in the previous year, indicating a worsening financial position[33][35] - Revenue decreased by approximately SGD 4.8 million or 34.5% from approximately SGD 13.9 million in fiscal year 2022 to approximately SGD 9.1 million in fiscal year 2023[67] - The overall gross profit decreased by approximately SGD 1.3 million or 216.7%, resulting in a gross loss of approximately SGD 0.7 million in fiscal year 2023, with the gross margin declining from approximately 4.6% to a gross loss margin of approximately 8.0%[69] Operational Performance - Operating loss increased to SGD 4,600,000 in 2023 from SGD 2,157,000 in 2022, indicating a significant decline in operational performance[4] - The segment loss for continuing operations was SGD 560,000 for the year ending December 31, 2023, compared to a profit of SGD 938,000 in the previous year, indicating a significant shift in performance[33][35] - The company has terminated its entertainment machines and equipment business operations during the year[10] - The company completed the sale of a subsidiary engaged in the trading of gaming machines and equipment, resulting in the termination of that segment's operations[31] Assets and Liabilities - The company's net assets decreased to SGD 2,869,000 in 2023 from SGD 9,125,000 in 2022, indicating a substantial reduction in equity[7] - The total assets decreased from SGD 16,317,000 in 2022 to SGD 10,059,000 in 2023, reflecting a reduction of approximately 38.4%[38] - As of December 31, 2023, the group's current liabilities due within one year amounted to approximately SGD 4,566,000, while cash and bank balances classified as current assets were approximately SGD 1,598,000[14] - The total liabilities remained relatively stable, with a slight decrease from SGD 7,192,000 in 2022 to SGD 7,190,000 in 2023, showing a marginal change of 0.03%[38] Cash Flow and Liquidity - Cash and cash equivalents decreased to SGD 1,598,000 in 2023 from SGD 2,271,000 in 2022, highlighting liquidity challenges[6] - The group has obtained a loan of SGD 2,000,000 from a shareholder post-reporting period to support cash flow[15] - The board believes that, assuming successful implementation of planned measures, the group will have sufficient working capital to meet its operational and financial obligations[15] - The current ratio as of December 31, 2023, was approximately 1.4 times, down from 2.4 times in 2022, mainly due to a decrease in inventory and cash balances[76] Shareholder and Corporate Governance - The company has adhered to the corporate governance code as per GEM Listing Rules, except for the separation of roles between the Chairman and CEO, which is currently held by Mr. Pan[103] - The audit committee, consisting of three independent non-executive directors, has reviewed the audited financial information for the fiscal year 2023 and confirmed compliance with applicable accounting standards and GEM Listing Rules[109] - The company has implemented trading standards for directors in accordance with GEM Listing Rules, with all directors confirming compliance for the fiscal year 2023[104] - The company is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance corporate value[103] Employee and Operational Capacity - The company had a total of 92 employees as of December 31, 2023, down from 126 employees in 2022, reflecting a reduction in operational capacity[84] - Total employee costs for the fiscal year 2023 amounted to approximately SGD 4.1 million, a decrease from SGD 4.7 million in fiscal year 2022[86] Financial Costs and Expenses - The company’s financial costs increased to SGD 176,000 in 2023 from SGD 144,000 in 2022, reflecting a rise of approximately 22.2%[33][35] - Interest expenses for continuing operations increased to SGD 159,000 in 2023 from SGD 124,000 in 2022, marking a rise of 28.2%[43] - The total expenses for continuing operations were SGD 13,823,000 in 2023, a decrease of 14.8% from SGD 16,243,000 in 2022[42] Impairment and Asset Valuation - The company reported a non-financial asset impairment loss of SGD 1,043,000, indicating challenges in asset valuation[4] - The company recorded an impairment loss of non-financial assets amounting to SGD 1.0 million, primarily from the manufacturing and sale of disposable medical devices[70] Revenue Sources - Revenue from Customer A for the year ended 2023 was SGD 6,818,000, a decrease of 12.9% from SGD 7,823,000 in 2022[39] - The segment revenue from gaming machines recognized at a point in time was SGD 7,560,000 for the year ending December 31, 2023, down from SGD 9,602,000 in the previous year, a decrease of about 21.4%[33][35] Compliance and Regulatory Matters - The company has not engaged in any business that directly or indirectly competes with its operations as of the announcement date[101] - The company has not purchased, sold, or redeemed any of its listed securities during the fiscal year 2023[97] - The company has not granted any stock options since the adoption of the stock option plan on December 19, 2017, and there are no unexercised options as of December 31, 2023[99]